Insider Transactions in Q3 2021 at Dicerna Pharmaceuticals Inc (DRNA)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 17
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
21,250
-98.76%
|
$446,250
$21.06 P/Share
|
|
Sep 17
2021
|
Shreeram Aradhye EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,056
-29.27%
|
$43,176
$21.47 P/Share
|
|
Sep 17
2021
|
Ling Zeng Chief Legal Officer & Sec'y |
SELL
Open market or private sale
|
Direct |
1,334
-29.28%
|
$28,014
$21.47 P/Share
|
|
Sep 15
2021
|
Shreeram Aradhye EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,025
+50.0%
|
-
|
|
Sep 15
2021
|
Ling Zeng Chief Legal Officer & Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct |
4,556
+50.0%
|
-
|
|
Aug 10
2021
|
Marc D Kozin Director |
BUY
Open market or private purchase
|
Direct |
3,000
+32.14%
|
$69,000
$23.66 P/Share
|
|
Aug 10
2021
|
Douglas Fambrough Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+10.38%
|
$110,000
$22.1 P/Share
|
|
Aug 02
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-27.87%
|
$307,544
$37.38 P/Share
|
|
Aug 02
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|
|
Jul 06
2021
|
James B Weissman Chief Operating Officer & EVP |
SELL
Open market or private sale
|
Direct |
30,000
-65.22%
|
$1,170,000
$39.09 P/Share
|
|
Jul 06
2021
|
James B Weissman Chief Operating Officer & EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+39.47%
|
$270,000
$9.09 P/Share
|
|
Jul 06
2021
|
Regina M. Paglia Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,404
-40.92%
|
$51,948
$37.05 P/Share
|
|
Jul 06
2021
|
Regina M. Paglia Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,162
+39.52%
|
-
|
|
Jul 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct |
8,312
-14.51%
|
$307,544
$37.57 P/Share
|
|
Jul 01
2021
|
Bob D Brown Chief Scientific Ofr., EVP R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+21.79%
|
$24,936
$3.42 P/Share
|